0001209191-19-019399.txt : 20190314 0001209191-19-019399.hdr.sgml : 20190314 20190314160622 ACCESSION NUMBER: 0001209191-19-019399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190312 FILED AS OF DATE: 20190314 DATE AS OF CHANGE: 20190314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cole G Bradley CENTRAL INDEX KEY: 0001337798 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 19681108 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-12 0 0001131324 GENOMIC HEALTH INC GHDX 0001337798 Cole G Bradley 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 CFO Common Stock 2019-03-12 4 M 0 5000 17.18 A 48722 I Held by the Cole Family Trust Common Stock 2019-03-12 4 M 0 10000 22.98 A 58722 I Held by the Cole Family Trust Common Stock 2019-03-12 4 S 0 4000 74.984 D 54722 I Held by the Cole Family Trust Common Stock 2019-03-12 4 S 0 1000 75.805 D 53722 I Held by the Cole Family Trust Common Stock 2019-03-12 4 S 0 7900 74.9768 D 45822 I Held by the Cole Family Trust Common Stock 2019-03-12 4 S 0 2100 75.8167 D 43722 I Held by the Cole Family Trust Employee Stock Option (right to buy) 17.18 2019-03-12 4 M 0 5000 0.00 D 2020-02-18 Common Stock 5000 21471 D Employee Stock Option (right to buy) 22.98 2019-03-12 4 M 0 10000 0.00 D 2021-01-27 Common Stock 10000 16424 D Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $74.53 to $75.42. Represents weighted average sale price. Actual sale prices ranged from $75.64 to $75.96. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 23, 2018. Represents weighted average sale price. Actual sale prices ranged from $74.52 to $75.44. Represents weighted average sale price. Actual sale prices ranged from $75.66 to $76.04. The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter. The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2019-03-14